Nuzenio

Stock Titan Clearmind

Stock Titan Clearmind entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Clearmind Medicine (Nasdaq: CMND) wins DSMB nod to advance AUD trial - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:03 GMTCMND-100 Set to Enter Human Testing for Moderate-to-Severe Alcohol Use Disorder - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTClearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMT24 Participants Complete Treatment in Clearmind's Alcohol Use Disorder Trial - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 20:01:03 GMTClearmind Medicine (Nasdaq: CMND) wins DSMB nod to advance AUD trial - Stock Titan
Thu, 06 Aug 2026 12:00:00 GMTCMND-100 Set to Enter Human Testing for Moderate-to-Severe Alcohol Use Disorder - Stock Titan
Thu, 30 Jul 2026 12:30:00 GMTClearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMT24 Participants Complete Treatment in Clearmind's Alcohol Use Disorder Trial - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Clearmind.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.